It also mediates the proteasomal degradation of mitochondrial proteins, such as MCL-1, to regulate the mitochondria-dependent apoptosis pathway [47], which suggests that further research on the role of the UPS in nuclear–mitochondrial interaction signaling may provide a basis for the development of UPS inhibitors to increase the sensitivity of traditional anti-cancer drugs. This evidence concerns the gene MCL1 and cancer.